Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion-Reference-Cited by-同舟云学术

Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion

Published:2016-02 Issue:2 Volume:123 Page:330-336
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Clark W. Lloyd,Boyer David S.^ORCID,Heier Jeffrey S.^ORCID,Brown David M.,Haller Julia A.,Vitti Robert,Kazmi Husain,Berliner Alyson J.,Erickson Kristine,Chu Karen W.,Soo Yuhwen,Cheng Yenchieh,Campochiaro Peter A.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference24 articles.

1. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study;Klein;Arch Ophthalmol,2008

2. Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature;Jaulim;Retina,2013

3. Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study;Sperduto;Ophthalmology,1998

4. Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion;Campochiaro;Ophthalmology,2013

5. Soluble vascular endothelial growth factor receptor-2 and inflammatory factors in macular edema with branch retinal vein occlusion;Noma;Am J Ophthalmol,2011

Cited by 211 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between time to treatment and outcome in branch retinal vein occlusion;International Ophthalmology;2024-08-25

2. Fatty Acid-Binding Protein 4-Mediated Regulation Is Pivotally Involved in Retinal Pathophysiology: A Review;International Journal of Molecular Sciences;2024-07-14

3. Aflibercept im klinischen Alltag: die AURIGA-Studie;Die Ophthalmologie;2024-07-08

4. Retinal Vein Occlusion–Background Knowledge and Foreground Knowledge Prospects—A Review;Journal of Clinical Medicine;2024-07-05

5. Disparities in Retinal Vein Occlusion Presentation and Initiation of Anti-VEGF Therapy;Ophthalmology Retina;2024-07